Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 16/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.59 |
| ▸ | LMNA | P02545 | 6/20 | 0.59 |
| ▸ | MEN1 | O00255 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | CRHBP | P24387 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 8/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | HTT | P42858 | 4/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30416035 | 1.00 | MAPT (0.59) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6816773 | 0.95 | MAPT (0.54) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6816766 | 0.95 | MAPT (0.54) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6811083 | 0.94 | L3MBTL1 (0.64) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6811086 | 0.94 | L3MBTL1 (0.64) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6563742 | 0.91 | MAPT (0.54) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6563751 | 0.91 | MAPT (0.54) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6813069 | 0.91 | MAPT (0.54) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6563745 | 0.91 | MAPT (0.54) | MAPTALDH1A1KDM4ELMNAMEN1 | |
| SCHEMBL6811637 | 0.91 | MAPT (0.54) | MAPTALDH1A1KDM4ELMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3732175-B1 | A CATALYST COMPOSITION FOR A PRODUCING PROCESS OF AN UNSATURATED CARBOXYLIC ACID SALT AND ITS DERIVATIVES FROM CARBON DIOXIDE AND OLEFIN | PTT GLOBAL CHEMICAL PUBLIC CO LTD (TH) | 2023-08-16 | — | — | EP | disclosed |
| US-10934243-B2 | Catalyst composition for a producing process of an unsaturated carboxylic acid salt and its derivatives from carbon dioxide and olefin | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2021-03-02 | — | — | US | disclosed |
| US-20200317598-A1 | A CATALYST COMPOSITION FOR A PRODUCING PROCESS OF AN UNSATURATED CARBOXYLIC ACID SALT AND ITS DERIVATIVES FROM CARBON DIOXIDE AND OLEFIN | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2020-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10934243-B2 | Catalyst composition for a producing process of an unsaturated carboxylic acid salt and its derivatives from carbon dioxide and olefin | DDT, BRPF3, PHF6 | MAPT 4583/4885ALDH1A1 3460/4885KDM4E 601/4885 |
| US-20200317598-A1 | A CATALYST COMPOSITION FOR A PRODUCING PROCESS OF AN UNSATURATED CARBOXYLIC ACID SALT AND ITS DERIVATIVES FROM CARBON DIOXIDE AND OLEFIN | DDT, BRPF3, PHF6 | MAPT 4603/4885ALDH1A1 3167/4885KDM4E 600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.